Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential benefits. Preliminary findings suggest that this higher dosage may enhance the drug's ability to regulate blood sugar, potentially offering improved outcomes for individuals with insulin resistance. Further research is underway to fully understand the